secwatch.observer — SEC 8-K summary
======================================

Issuer:     ONCOLYTICS BIOTECH INC (ONCY)
CIK:        0001129928
Form:       8-K
Filed at:   2026-06-16T13:05:18+00:00
Accession:  0001129928-26-000041
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncolytics secures new U.S. patent for pelareorep manufacturing through 2044; method-of-use app to 2046
--------------------------------------------------------------------------------

- USPTO issued patent covering pelareorep manufacturing process, expected protection into 2044.
- Previously filed method-of-use patent application under review, if issued would protect into 2046.
- Company plans additional patent filings in 2026 to expand IP across therapeutic applications and combinations.
- CEO states patent supports commercial-scale production and long-term value of pelareorep.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1129928/000112992826000041/0001129928-26-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1129928/000112992826000041/oncy-20260616.htm
  HTML page:      https://secwatch.observer/filing/0001129928-26-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer